Pfizer and Merck KGaA commence late-stage trials of avelumab in gastric cancers
The immunotherapy avelumab will be tested in gastric cancer.
For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org
Together, we will defeat stomach cancer.
Together, we will defeat stomach cancer.
MORE INFODONATE